ClinicalTrials.gg
RecruitingNCT07903792Updated Oct 29, 2026

Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric Patient

An interventional study of Respiratory physiothperapy and Oropharyngeal suction in Cystic Fibrosis (CF) and Bronchiectasis, Non-Cystic Fibrosis, sponsored by Corporacion Parc Tauli. Recruiting at 1 site in Spain. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Corporacion Parc Tauli · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
196
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

The goal of this clinical trial is to determine the effectiveness of oropharyngeal suction in detecting microorganisms by comparing it with induced sputum and oropharyngeal swab samples. It also aims to assess the effect of respiratory physiotherapy on improving the results obtained in children aged 5-18 years with chronic lung disease.

The main questions it aims to answer are:

  • What is the diagnostic efficacy of oropharyngeal suction in detecting microorganisms compared with induced sputum?
  • What is the effect of undergoing a physiotherapy session before sample collection?
  • How do the results obtained from oropharyngeal suction correlate with those obtained from oropharyngeal swabs?
  • How does the age of the participants affect the results obtained from each sampling technique and the effect of prior physiotherapy?
  • Are these techniques safe?

Researchers will compare samples collected after a physiotherapy session with those collected without prior physiotherapy to determine whether physiotherapy improves culture results.

Participants will be randomized into two groups: one group will undergo a physiotherapy session before sample collection, while the other will not. Three samples will be collected from each participant using oropharyngeal suction, an oropharyngeal swab, and induced sputum. Each participant may take part on multiple occasions, provided that at least one month has elapsed since their previous participation. On each occasion, participants will be randomized again.

Read the detailed description

Oropharyngeal suction (OPS) is a technique used to obtain respiratory samples from children with chronic respiratory diseases who have difficulty expectorating. However, its diagnostic performance has not been sufficiently compared with that of other sampling techniques commonly used in clinical practice, such as induced sputum (IS) and oropharyngeal swab (OS).

Induced sputum is a recommended comparator for evaluating respiratory sampling techniques in patients who have difficulty producing sputum spontaneously. This study will compare the results obtained using OPS with those obtained using IS and OS to assess the agreement between these methods in detecting respiratory microorganisms.

In addition, the effect of respiratory physiotherapy prior to sample collection has not been sufficiently investigated in this population. Respiratory physiotherapy promotes the mobilization and clearance of airway secretions and may improve sample quality and increase the detection of respiratory pathogens.

This study aims to assess the diagnostic performance of OPS compared with IS and OS and to determine whether respiratory physiotherapy prior to sample collection improves the detection of respiratory microorganisms in children with chronic respiratory diseases. An exploratory analysis will also investigate potential differences between age subgroups (5-11 years and 12-18 years).

Study Design This is a randomized, controlled clinical trial with two parallel groups. Participants will be randomized to undergo respiratory physiotherapy before sample collection or to undergo sample collection without prior respiratory physiotherapy.

Primary Objective To assess the diagnostic performance of OPS for detecting microorganisms by comparing the results with those obtained from IS, used as the reference comparator.

Secondary Objectives To assess the agreement between OPS and OS in detecting respiratory microorganisms; to evaluate whether respiratory physiotherapy prior to sample collection improves microorganism detection; to compare the results obtained using the different sampling techniques; to explore whether the diagnostic performance of the sampling techniques and the effect of respiratory physiotherapy differ between age subgroups (5-11 years and 12-17 years); and to assess the safety and tolerability of the sampling procedures.

Study Procedures and Intervention Participants will undergo sample collection using three consecutive sampling procedures: oropharyngeal swab (OS), oropharyngeal suction (OPS), and induced sputum (IS).

Participants will be randomized to one of two groups. In the intervention group, a respiratory physiotherapy session will be performed before sample collection. In the control group, samples will be collected without a prior respiratory physiotherapy session.

If a participant is unable to expectorate a sputum sample following the induced sputum procedure, oropharyngeal suction will be repeated. In these cases, the sampling sequence will consist of OS, OPS, and a second OPS procedure following induced sputum (OPS_postIS).

All samples will be processed according to standard laboratory protocols. Laboratory personnel responsible for processing and analysing the samples will remain blinded to the intervention allocation.

Culture results will be compared across the different sampling techniques, focusing on the presence or absence of microorganisms.

Participants may take part in more than one study visit, provided that at least one month has elapsed since their previous participation. Randomization will be performed again at each participation, according to the study protocol.

Study Population The study population will consist of children aged 5-18 years with chronic respiratory diseases who require sputum sampling for microbiological culture and are followed by the Paediatric Pulmonology Unit at Hospital Taulí, Sabadell, Spain.

Eligible conditions include cystic fibrosis (CF), non-cystic fibrosis bronchiectasis (NCFB), protracted bacterial bronchitis (PBB), and recurrent pneumonia.

Statistical Analysis Descriptive statistics will be used to summarize the study data. Quantitative variables will be described using means and standard deviations or medians and interquartile ranges, as appropriate. Categorical variables will be summarized using frequencies and percentages.

The diagnostic performance of OPS will be assessed by comparing its culture results with those obtained from IS. Sensitivity, specificity, and positive and negative predictive values will be calculated where appropriate. Agreement between sampling methods will be evaluated using Cohen's kappa coefficient with 95% confidence intervals, using IS as the reference comparator.

Exploratory subgroup analyses will investigate potential differences between children aged 5-11 years and those aged 12-18 years. The effect of respiratory physiotherapy on microorganism detection will also be assessed by comparing the results between the randomized groups.

The statistical significance level will be set at 0.05.

Safety Assessment Adverse events occurring during the sample collection procedures will be recorded to assess the safety and tolerability of the sampling techniques and the respiratory physiotherapy intervention.

02

Conditions studied

  • Cystic Fibrosis (CF)
  • Bronchiectasis, Non-Cystic Fibrosis

Keywords

  • Cystic Fibrosis
  • Bronchiectasis
  • Bacterial
  • Sputum culture
  • Orofaringeal swab
  • Respiratory physiotherapy
  • Oropharyngeal suction
  • induced sputum
03

In context

Cystic Fibrosis

1,609 studies on the registry are indexed under Cystic Fibrosis; 197 are open to participants now.

This study's planned enrollment of 196 is above the median of 36 across 1,052 interventional studies indexed under Cystic Fibrosis.

Browse Cystic Fibrosis studies →

Lead sponsor

Corporacion Parc Tauli is the lead sponsor of 167 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having a chronic respiratory disease that requires sputum sample collection.
  • Being able to cooperate during the physiotherapy session.
  • Having provided signed informed consent.

Exclusion criteria

Exclusion Criteria:

  • Severe acute infection that contraindicates any of the procedures (e.g., severe respiratory failure, shock, etc.).
  • Having taken antibiotics in the previous week, except for patients receiving chronic azithromycin treatment.
  • Decompensated cardiorespiratory disease.
  • History of severe adverse reactions to hypertonic saline nebulization.
  • Patients who do not consent to or are unable to undergo the procedures.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
196 participants (estimated)

Study arms

  • Experimental
    Physiotherapy group

    Participants will undergo a physiotherapy session before sample collection, consisting of inspiratory exercises and airway clearance techniques. Following the session, three samples will be collected: oropharyngeal swap, oropharyngeal suction, and induced sputum.

    Other: Respiratory physiothperapy · Other: Oropharyngeal suction · Other: Oropharyngeal swab · Other: Induced Sputum

  • Other
    Non-Physiotherapy group

    Three samples will be collected: oropharyngeal swab, oropharyngeal suction, and induced sputum.

    Other: Oropharyngeal suction · Other: Oropharyngeal swab · Other: Induced Sputum

Interventions

  • OtherRespiratory physiothperapy

    It has not been studied whether carrying out a respiratory physiotherapy session prior to sampling improves the diagnostic performance of the different methods.

  • OtherOropharyngeal suction

    Sterile aspiration of the oropharyngeal area to collect mucus.

  • OtherOropharyngeal swab

    Sterile swab of the oropharyngeal area to collect mucus.

  • OtherInduced Sputum

    Collection of expectorated sputum after a 15-minute nebulization with a 4.5% hypertonic saline solution

06

What researchers measure

Primary outcomes

  1. Presence/absence of microorganisms in each sample, as a binary variable

    To determine the diagnostic efficacy of oropharyngeal suction, the detection of the studied microorganisms in the samples obtained using this method will be evaluated as a binary variable (presence/absence). The microorganisms studied are: * Staphylococcus aureus, methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) * Pseudomonas aeruginosa (PA) * Haemophilus influenzae (HI) * Streptococcus pneumoniae (SP) * Enterobacter cloacae (EC) * Burkholderia cepacia (BC) * Moraxella catarrhalis (MC) * Mycobacterium abscessus (MA) * Aspergillus fumigatus (AF) * Other From these variables, the following derived indicators will be obtained: * Suction vs. induced sputum agreement (percentage agreement and kappa coefficient) * Suction sensitivity * Suction specificity

    Time frame: At baseline

Secondary outcomes

  1. Presence/absence of microorganisms in Oropharyngeal Suction and Induced Sputum obtained post-physiotherapy

    To determine the effect of a physiotherapy session prior to sample collection, the presence/absence of the studied microorganisms in samples obtained by suction and those obtained through induced sputum will be evaluated. The following derived indicators will be compared with those of the group that has NOT undergone prior physiotherapy to determine whether this improves the agreement between the methods: * Suction and induced sputum agreement by group (κ and % agreement) * Sensitivity and specificity stratified by group

    Time frame: At baseline

  2. Presence/absence of microorganisms in oropharyngeal swab and oropharyngeal suction

    To compare the results obtained from samples collected by oropharyngeal swab and those obtained by oropharyngeal suction, the presence or absence of the microorganisms studied will be determined in both samples. The degree of agreement will be calculated as a derived indicator (κ and percentage of agreement).

    Time frame: At baseline

  3. Sensitivity and specificity of oropharyngeal suction and oropharyngeal swab compared to induced sputum

    It will be determined by the proportions of true positives and true negatives, respectively, relative to induced sputum, which is considered the reference method.

    Time frame: At baseline

  4. Age

    Quantitative variable (years), which will be categorized into two subgroups for analysis: children (5-11 years) and adolescents (12-18 years). It will be used as a potential effect modifier in the analysis of diagnostic concordance and response to respiratory physiotherapy.

    Time frame: At baseline

  5. Oxygen saturation

    Oxygen saturation (as a percentage) to determine safety of the three sample taking methods.

    Time frame: Before and immediately after the procedure

  6. Heart rate

    Heart rate (in beats per minute) will be recorded before and after sample collection to determine the safety of each technique.

    Time frame: Before and immediately after the procedure

  7. Presence/absence of adverse effects

    The presence or absence of the following adverse effects will be recorded both during sample collection and on the following day: * Irritative/persistent cough * Vomiting * Nausea * Other (specify)

    Time frame: During the procedure and up to 24 hours post-procedure.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Marguet C, Houdouin V, Pin I, Reix P, Huet F, Mittaine M, Ramel S, Wizla-Derambure N, Abely M, Dalphin ML, Fayon M, Bihouee T, Le Bourgeois M, Deneuville E, Corvol H, Laurans M, Couderc L, Leroux E, Lemee L. Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis. ERJ Open Res. 2021 Mar 8;7(1):00513-2020. doi: 10.1183/23120541.00513-2020. eCollection 2021 Jan. PubMed 33718497 ↗
  • Avital A, Uwyyed K, Picard E, Godfrey S, Springer C. Sensitivity and specificity of oropharyngeal suction versus bronchoalveolar lavage in identifying respiratory tract pathogens in children with chronic pulmonary infection. Pediatr Pulmonol. 1995 Jul;20(1):40-3. doi: 10.1002/ppul.1950200108. PubMed 7478780 ↗
  • Doumit M, Belessis Y, Stelzer-Braid S, Mallitt KA, Rawlinson W, Jaffe A. Diagnostic accuracy and distress associated with oropharyngeal suction in cystic fibrosis. J Cyst Fibros. 2016 Jul;15(4):473-8. doi: 10.1016/j.jcf.2015.09.001. Epub 2015 Sep 18. PubMed 26388518 ↗
  • Wang L, Yang S, Yan X, Liu T, Feng Z, Li G. Comparing the yield of oropharyngeal swabs and sputum for detection of 11 common pathogens in hospitalized children with lower respiratory tract infection. Virol J. 2019 Jun 24;16(1):84. doi: 10.1186/s12985-019-1177-x. PubMed 31234918 ↗
  • Serigstad S, Knoop ST, Markussen DL, Ulvestad E, Bjorneklett RO, Ebbesen MH, Kommedal O, Grewal HMS. Diagnostic utility of oropharyngeal swabs as an alternative to lower respiratory tract samples for PCR-based syndromic testing in patients with community-acquired pneumonia. J Clin Microbiol. 2023 Sep 21;61(9):e0050523. doi: 10.1128/jcm.00505-23. Epub 2023 Aug 16. PubMed 37585220 ↗
  • Zampoli M, Pillay K, Carrara H, Zar HJ, Morrow B. Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis. J Cyst Fibros. 2016 Sep;15(5):605-10. doi: 10.1016/j.jcf.2016.01.001. Epub 2016 Jan 26. PubMed 26825010 ↗
  • Eyns H, Pierard D, De Wachter E, Eeckhout L, Vaes P, Malfroot A. Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis. Front Pediatr. 2018 Dec 18;6:403. doi: 10.3389/fped.2018.00403. eCollection 2018. PubMed 30619797 ↗
  • Wang H, Li X, Zheng Y, Verhagen LM, Gu J, Li L, Xu Z, Wang W, de Jonge MI. Concordance in pathogen identification at the upper and lower respiratory tract of children with severe pneumonia. BMC Infect Dis. 2023 Mar 20;23(1):170. doi: 10.1186/s12879-023-08127-w. PubMed 36941581 ↗
  • Prevaes SM, de Steenhuijsen Piters WA, de Winter-de Groot KM, Janssens HM, Tramper-Stranders GA, Chu ML, Tiddens HA, van Westreenen M, van der Ent CK, Sanders EA, Bogaert D. Concordance between upper and lower airway microbiota in infants with cystic fibrosis. Eur Respir J. 2017 Mar 29;49(3):1602235. doi: 10.1183/13993003.02235-2016. Print 2017 Mar. PubMed 28356374 ↗
  • Fenn D, Abdel-Aziz MI, Brinkman P, Kos R, Neerincx AH, Altenburg J, Weersink E, Haarman EG, Terheggen-Lagro SWJ, Maitland-van der Zee AH, Bos LDJ; Amsterdam mucociliary clearance disease research group. Comparison of microbial composition of cough swabs and sputum for pathogen detection in patients with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):52-60. doi: 10.1016/j.jcf.2021.08.031. Epub 2021 Sep 20. PubMed 34548223 ↗
  • Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT. The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial. Lancet Respir Med. 2018 Jun;6(6):461-471. doi: 10.1016/S2213-2600(18)30171-1. Epub 2018 May 16. PubMed 29778403 ↗
  • Dubourg G, Abat C, Rolain JM, Raoult D. Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol. 2015 Mar;53(3):994-6. doi: 10.1128/JCM.02918-14. Epub 2014 Dec 24. PubMed 25540405 ↗
  • Blau H, Linnane B, Carzino R, Tannenbaum EL, Skoric B, Robinson PJ, Robertson C, Ranganathan SC. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children. J Cyst Fibros. 2014 Jan;13(1):106-10. doi: 10.1016/j.jcf.2013.05.013. Epub 2013 Jun 24. PubMed 23806622 ↗
  • Luo W, Lin Y, Li Z, Wang W, Shi Y. Comparison of sputum induction and bronchoscopy in diagnosis of sputum smear-negative pulmonary tuberculosis: a systemic review and meta-analysis. BMC Pulm Med. 2020 May 25;20(1):146. doi: 10.1186/s12890-020-01192-w. PubMed 32450826 ↗
  • Ogawa M, Hoshina T, Abushawish A, Kusuhara K. Evaluation of the usefulness of culture of induced sputum and the optimal timing for the collection of a good-quality sputum sample to identify causative pathogen of community-acquired pneumonia in young children: A prospective observational study. J Microbiol Immunol Infect. 2023 Oct;56(5):1036-1044. doi: 10.1016/j.jmii.2023.05.005. Epub 2023 Jun 2. PubMed 37302895 ↗
  • Wurzel DF, Marchant JM, Yerkovich ST, Upham JW, Mackay IM, Masters IB, Chang AB. Prospective characterization of protracted bacterial bronchitis in children. Chest. 2014 Jun;145(6):1271-1278. doi: 10.1378/chest.13-2442. PubMed 24435356 ↗
  • Tsouprou M, Koumpagioti D, Botsa E, Douros K, Moriki D. Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review. Antibiotics (Basel). 2025 Feb 7;14(2):165. doi: 10.3390/antibiotics14020165. PubMed 40001409 ↗
  • de Dios Caballero J, Del Campo R, Royuela A, Sole A, Maiz L, Olveira C, Quintana-Gallego E, de Gracia J, Cobo M, de la Pedrosa EG, Oliver A, Canton R; GEIFQ (Grupo Espanol para el Estudio de la Colonizacion/Infeccion Broncopulmonar en Fibrosis Quistica). Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study. J Cyst Fibros. 2016 May;15(3):357-65. doi: 10.1016/j.jcf.2015.09.004. Epub 2015 Sep 28. PubMed 26429520 ↗
  • Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, Sermet-Gaudelus I, Southern KW, Taccetti G, Ullrich G, Wolfe S; European Cystic Fibrosis Society. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros. 2014 May;13 Suppl 1:S23-42. doi: 10.1016/j.jcf.2014.03.010. PubMed 24856775 ↗
  • Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC; Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc. 2014 Dec;11(10):1640-50. doi: 10.1513/AnnalsATS.201404-166OC. PubMed 25549030 ↗

Individual participant data

Plan to share: Undecided

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07903792
Responsible party
Alba Valls-Llovera (Physiotherapist, Corporacion Parc Tauli) — Principal investigator
First posted
Oct 29, 2026
Start date
Jun 1, 2026
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Oct 29, 2026

Study contacts

Alba Valls-Llovera
Contact
avallsl@tauli.cat
+34644253942

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion